Aarti Drugs Ltd
Aarti Drugs Ltd Share Price Today: Live Updates & Key Insights
Get insights on Aarti Drugs Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Aarti Drugs Ltd Share Price Chart
Aarti Drugs Ltd Fundamentals
Traded Volume: 4,12,614
Market Cap(Cr): 4,518
Avg Traded Price 199.50
1 Year return -0.57%
Upper Circuit 499.9
Lower Circuit 479.5
P/E TTM 23.00
P/B Ratio 22.00
Traded Value(Cr) 2027.79
EPS TTM 21.814
Book value 21.814
Dividend 0.00%
Aarti Drugs Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Aarti Drugs Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Aarti Drugs Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -2.10%
1M -1.57%
3M +0.06%
1Y -0.57%
YTD +7.33%
Aarti Drugs Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Aarti Drugs Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 98582.00
Day Before Yesterday 87386.00
1W Avg 89330.50
1M Avg 1.36L
3M Avg 1.64L
Aarti Drugs Ltd Technical Details
Aarti Drugs Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 481
Support 2 470
Support 3 460
Pivot Point : 490
Resistance 1 501
Resistance 2 511
Resistance 3 521
Aarti Drugs Ltd Corporate Actions
Aarti Drugs Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Aarti Drugs Ltd’s capital allocation strategies.
All
Ex-Date 04-Feb-2025 Type D Description 1.00/share@10.00% Record Date 04-Feb-2025 Ratio 10.00
Ex-Date 05-Sep-2024 Type T Description /share@% Record Date 07-Nov-2025 Ratio
Ex-Date 05-Sep-2024 Type T Description /share@% Record Date 07-Nov-2025 Ratio
Ex-Date 06-Feb-2024 Type D Description 1.00/share@10.00% Record Date 06-Feb-2024 Ratio 10.00
Ex-Date 04-Aug-2023 Type T Description /share@% Record Date 07-Nov-2025 Ratio
Ex-Date 08-Feb-2023 Type D Description 1.00/share@10.00% Record Date 08-Feb-2023 Ratio 10.00
Ex-Date 09-Feb-2022 Type D Description 1.00/share@10.00% Record Date 10-Feb-2022 Ratio 10.00
Ex-Date 30-Mar-2021 Type T Description /share@% Record Date 07-Nov-2025 Ratio
Ex-Date 03-Nov-2020 Type D Description 2.50/share@25.00% Record Date 04-Nov-2020 Ratio 25.00
Ex-Date 30-Sep-2020 Type B Description share@3:1 Record Date 01-Oct-2020 Ratio 3:1
Ex-Date 17-Feb-2020 Type D Description 2.00/share@20.00% Record Date 18-Feb-2020 Ratio 20.00
Ex-Date 26-Jul-2019 Type D Description 1.00/share@10.00% Record Date 07-Nov-2025 Ratio 10.00
Ex-Date 28-Mar-2019 Type T Description /share@% Record Date 07-Nov-2025 Ratio
Ex-Date 01-Aug-2018 Type D Description 1.00/share@10.00% Record Date 07-Nov-2025 Ratio 10.00
Ex-Date 18-Jan-2018 Type T Description /share@% Record Date 07-Nov-2025 Ratio
Ex-Date 09-Aug-2017 Type D Description 1.00/share@10.00% Record Date 07-Nov-2025 Ratio 10.00
Ex-Date 01-Nov-2016 Type T Description /share@% Record Date 07-Nov-2025 Ratio
Ex-Date 22-Mar-2016 Type D Description 3.00/share@30.00% Record Date 24-Mar-2016 Ratio 30.00
Ex-Date 12-Feb-2016 Type D Description 1.50/share@15.00% Record Date 15-Feb-2016 Ratio 15.00
Ex-Date 10-Nov-2015 Type D Description 2.25/share@22.50% Record Date 14-Nov-2015 Ratio 22.50
Ex-Date 05-Aug-2015 Type D Description 3.00/share@30.00% Record Date 07-Nov-2025 Ratio 30.00
Ex-Date 24-Mar-2015 Type B Description share@1:1 Record Date 25-Mar-2015 Ratio 1:1
Ex-Date 04-Feb-2015 Type D Description 5.00/share@50.00% Record Date 05-Feb-2015 Ratio 50.00
Ex-Date 19-Nov-2014 Type D Description 5.00/share@50.00% Record Date 20-Nov-2014 Ratio 50.00
Ex-Date 02-Jul-2014 Type D Description 5.50/share@55.00% Record Date 07-Nov-2025 Ratio 55.00
Ex-Date 05-Feb-2014 Type D Description 4.50/share@45.00% Record Date 06-Feb-2014 Ratio 45.00
Ex-Date 19-Nov-2013 Type D Description 3.00/share@30.00% Record Date 14-Nov-2013 Ratio 30.00
Ex-Date 24-Jul-2013 Type D Description 4.00/share@40.00% Record Date 07-Nov-2025 Ratio 40.00
Ex-Date 11-Feb-2013 Type D Description 3.00/share@30.00% Record Date 12-Feb-2013 Ratio 30.00
Ex-Date 05-Nov-2012 Type D Description 3.00/share@30.00% Record Date 06-Nov-2012 Ratio 30.00
Ex-Date 17-Aug-2012 Type D Description 3.00/share@30.00% Record Date 07-Nov-2025 Ratio 30.00
Ex-Date 06-Feb-2012 Type D Description 2.00/share@20.00% Record Date 07-Feb-2012 Ratio 20.00
Ex-Date 14-Jul-2011 Type D Description 2.50/share@25.00% Record Date 07-Nov-2025 Ratio 25.00
Ex-Date 07-Feb-2011 Type D Description 2.50/share@25.00% Record Date 08-Feb-2011 Ratio 25.00
Ex-Date 18-Aug-2010 Type D Description 5.00/share@50.00% Record Date 07-Nov-2025 Ratio 50.00
Ex-Date 23-Jul-2009 Type D Description 3.00/share@30.00% Record Date 07-Nov-2025 Ratio 30.00
Ex-Date 13-Aug-2008 Type D Description 1.80/share@18.00% Record Date 07-Nov-2025 Ratio 18.00
Ex-Date 20-Mar-2007 Type D Description 1.20/share@12.00% Record Date 21-Mar-2007 Ratio 12.00
Dividends
Announcement Date 04-Feb-2025 Ex Dividend Date 04-Feb-2025 Dividend(%) 10
Announcement Date 06-Feb-2024 Ex Dividend Date 06-Feb-2024 Dividend(%) 10
Announcement Date 08-Feb-2023 Ex Dividend Date 08-Feb-2023 Dividend(%) 10
Announcement Date 09-Feb-2022 Ex Dividend Date 09-Feb-2022 Dividend(%) 10
Announcement Date 03-Nov-2020 Ex Dividend Date 03-Nov-2020 Dividend(%) 25
Announcement Date 17-Feb-2020 Ex Dividend Date 17-Feb-2020 Dividend(%) 20
Announcement Date 26-Jul-2019 Ex Dividend Date 26-Jul-2019 Dividend(%) 10
Announcement Date 01-Aug-2018 Ex Dividend Date 01-Aug-2018 Dividend(%) 10
Announcement Date 09-Aug-2017 Ex Dividend Date 09-Aug-2017 Dividend(%) 10
Announcement Date 22-Mar-2016 Ex Dividend Date 22-Mar-2016 Dividend(%) 30
Announcement Date 12-Feb-2016 Ex Dividend Date 12-Feb-2016 Dividend(%) 15
Announcement Date 10-Nov-2015 Ex Dividend Date 10-Nov-2015 Dividend(%) 23
Announcement Date 05-Aug-2015 Ex Dividend Date 05-Aug-2015 Dividend(%) 30
Announcement Date 04-Feb-2015 Ex Dividend Date 04-Feb-2015 Dividend(%) 50
Announcement Date 19-Nov-2014 Ex Dividend Date 19-Nov-2014 Dividend(%) 50
Announcement Date 02-Jul-2014 Ex Dividend Date 02-Jul-2014 Dividend(%) 55
Announcement Date 05-Feb-2014 Ex Dividend Date 05-Feb-2014 Dividend(%) 45
Announcement Date 19-Nov-2013 Ex Dividend Date 19-Nov-2013 Dividend(%) 30
Announcement Date 24-Jul-2013 Ex Dividend Date 24-Jul-2013 Dividend(%) 40
Announcement Date 11-Feb-2013 Ex Dividend Date 11-Feb-2013 Dividend(%) 30
Announcement Date 05-Nov-2012 Ex Dividend Date 05-Nov-2012 Dividend(%) 30
Announcement Date 17-Aug-2012 Ex Dividend Date 17-Aug-2012 Dividend(%) 30
Announcement Date 06-Feb-2012 Ex Dividend Date 06-Feb-2012 Dividend(%) 20
Announcement Date 14-Jul-2011 Ex Dividend Date 14-Jul-2011 Dividend(%) 25
Announcement Date 07-Feb-2011 Ex Dividend Date 07-Feb-2011 Dividend(%) 25
Announcement Date 18-Aug-2010 Ex Dividend Date 18-Aug-2010 Dividend(%) 50
Announcement Date 23-Jul-2009 Ex Dividend Date 23-Jul-2009 Dividend(%) 30
Announcement Date 13-Aug-2008 Ex Dividend Date 13-Aug-2008 Dividend(%) 18
Announcement Date 20-Mar-2007 Ex Dividend Date 20-Mar-2007 Dividend(%) 12
Bonus
Record Date 01-Oct-2020 Ex-Bonus Date 30-Sep-2020 Ratio 3:1
Record Date 25-Mar-2015 Ex-Bonus Date 24-Mar-2015 Ratio 1:1
Splits
No Split has been declared by AARTIDRUGS
Others
Ex-Rights Date 05-Sep-2024 Premium(Rs.) Ratio
Ex-Rights Date 05-Sep-2024 Premium(Rs.) Ratio
Ex-Rights Date 04-Aug-2023 Premium(Rs.) Ratio
Ex-Rights Date 30-Mar-2021 Premium(Rs.) Ratio
Ex-Rights Date 28-Mar-2019 Premium(Rs.) Ratio
Ex-Rights Date 18-Jan-2018 Premium(Rs.) Ratio
Ex-Rights Date 01-Nov-2016 Premium(Rs.) Ratio
Aarti Drugs Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Aarti Drugs Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Aarti Drugs Ltd's relative performance and valuation against major competitors.
Stock Name Sequent Scientific Ltd ₹214.79 (-0.76%) M. Cap (Cr) 54.08 1 Yr Return (%) -3.08% P/E (TTM) 148.36 PB Ratio 7.95
Stock Name Gujarat Themis Biosyn Ltd ₹450.20 (+0.18%) M. Cap (Cr) 49.06 1 Yr Return (%) +35.44% P/E (TTM) 110.01 PB Ratio 21.96
Stock Name Zota Health Care Ltd ₹1535.20 (+0.44%) M. Cap (Cr) 46.57 1 Yr Return (%) +150.40% P/E (TTM) -76.32 PB Ratio 29.07
Stock Name Aarti Drugs Ltd ₹491.45 (+0.52%) M. Cap (Cr) 45.18 1 Yr Return (%) -0.57% P/E (TTM) 22.53 PB Ratio 3.51
Stock Name Innova Captab Ltd ₹767.50 (-4.42%) M. Cap (Cr) 43.92 1 Yr Return (%) -8.92% P/E (TTM) 35.29 PB Ratio 4.58
Stock Name Sun Pharma Advanced Research Company Ltd ₹133.35 (-0.91%) M. Cap (Cr) 43.28 1 Yr Return (%) -37.87% P/E (TTM) -14.50 PB Ratio -55.93
Stock Name Orchid Pharma Ltd ₹841.55 (+1.42%) M. Cap (Cr) 42.68 1 Yr Return (%) -41.98% P/E (TTM) 50.09 PB Ratio 3.49
Aarti Drugs Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Aarti Drugs Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 220.08 Mar 2024 337.10 Mar 2023 162.28 Mar 2022 39.90 Mar 2021 154.08
PARTICULARS Investing Activities Mar 2025 -134.92 Mar 2024 -187.09 Mar 2023 -131.14 Mar 2022 -125.36 Mar 2021 -68.93
PARTICULARS Financing Activities Mar 2025 -84.60 Mar 2024 -148.81 Mar 2023 -30.54 Mar 2022 84.11 Mar 2021 -85.28
PARTICULARS Net Cash Flow Mar 2025 0.56 Mar 2024 1.20 Mar 2023 0.61 Mar 2022 -1.35 Mar 2021 -0.13
Aarti Drugs Ltd Shareholding Pattern
This shows the ownership breakdown of Aarti Drugs Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 54.72%
Public 32.7%
Other Institutions 0.09%
FII 2.68%
Mutual Funds 9.81%
About Aarti Drugs Ltd
Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals. The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million. With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs. Company also operates Pinnacle Life Science Private Limited, its wholly owned subsidiary focused on formulation development.The Company has two R&D divisions, one in Tarapur and the other in Turbhe, Maharashtra. It has 3 subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA (foreign subsidiary). Of the above subsidiaries, Pinnacle Life Science Private Limited and Aarti Speciality Chemicals Limited are wholly owned subsidiaries.The manufacturing units of the Company are GMP certified. Their products include Active Pharmaceutical Ingredients (APIs), Steroids, Pharmaceutical Intermediates, and Specialty Chemicals, such as Benzene Sulphonyl Chloride, Benzene Sulphonic Acid/ Ammonium/ Sodium Salt and Benzene Sulphonamide. In 1993, the company implemented the second phase of their backward integration project and set up facilities for glyoxal (the main raw material for imidazoles). During the year 1994-95, the company commissioned a plant to recover and market ammonium sulphate derived from plant effluents. Also, Rupal Chemical Industries, a group company, was amalgamated with the company.During the year 1996-97, the company started their production of secnidazole and dichlofenac sodium. During the year 2000-01, they started the commercial production of Pharmaceutical Ingredients. During the year 2002-03, the company expanded the production capacity of bulk drugs by 598,000 kg to 17,430,000 kg. During the year 2003-04, the company further expanded the production capacity of bulk drugs by 588,000 kg to 18,018,000 kg. During the year 2004-05, the company started commercial production at their newly setup intermediate plant at Tarapur. During the year 2005-06, the company increased the production capacity of Pharmaceutical by 2,325,000 kg to 24,020,000 kg. They entered into joint venture with Chinese company engaged in Active Pharmaceutical Ingredients (APIs) manufacturing and formed Huanggang Yinhe Aarti Pharmaceutical Company Ltd for manufacturing and selling of APIs in China. Also, they acquired controlling stake in Suyash Laboratories Ltd so as to make the said company a subsidiary of the company.During the year 2006-07, the company increased the production capacity by 570,000 kg to 24,590,000 kg. During the next year, they increased the production capacity by 399,000 kg to 24,989,000 kg. During the year 2008-09, they further increased the production capacity of Pharmaceutical by 50,000 kg to 25,000,000 kg.During the year 2009-10, the company carried out process improvement work in bulk drugs, such as antihistaminic/anti-allergic, anti-inflammatory and anti-diabetic. ADL expanded the production capacity from 25,000,000 kg to 25,716,000 kg. A Scheme of Amalgamation of Suyash Laboratories Ltd., wholly owned subsidiary of the Company, with the Company became operative w.e.f. from 6th July, 2012.During year 2015, Company acquired 100% equity shares in Pinnacle Life Science Pvt. Ltd., situated at Baddi, Himachal Pradesh. During year 2020, Company incorporated 2 overseas Subsidiaries and 1 Domestic subsidiary Company. Pinnacle Chile SpA, incorporated in Santiago, Chile, was established for marketing the formulation of drugs and participating in the tender and private market in Chile. Aarti Speciality Chemicals Limited (Wholly Owned Subsidiary), in Mumbai, was carrying on business of manufacturers, producers, processors, buyers, sellers, importers, exporters or otherwise dealers in Speciality and other chemicals, pharmaceutical and drugs. Company commissioned brownfield expansion of Speciality Chemical Plant at Tarapur, which turned operational effective from May, 2022. The first project, located at the Tarapur Facility, for dermatology products has commenced operation in FY 2024-25.
CMD & CEO
Prakash M Patil
Registered office Plot No N-198 MIDC Tarapur, Pamtembhi Village Palghar Tal, Thane, Maharashtra, 401506
FAX :91-22-24072249
Background
Incorporation Year 1984
Face Value ₹10.00
Market Lot 1
FAQs on Aarti Drugs Ltd
How to buy Aarti Drugs Ltd shares on NSE?
To buy Aarti Drugs Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Aarti Drugs Ltd share price today?
The Aarti Drugs Ltd share price on NSE is ₹491.45 today.
What is the market cap of Aarti Drugs Ltd on NSE?
The company has a market capitalization of ₹4518.15.
What is the PE & PB ratio of Aarti Drugs Ltd?
PE is 23 and PB is 22.
What is the 52 Week High and Low of Aarti Drugs Ltd shares?
Aarti Drugs Ltd stock price high: ₹564.05 Aarti Drugs Ltd stock price low: ₹312.